Published in Int J Cancer on June 20, 1997
The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer (2005) 3.40
Retracted A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities. Proc Natl Acad Sci U S A (2008) 1.69
Histotype-based prognostic classification of gastric cancer. World J Gastroenterol (2012) 0.94
ERCC1 as a biomarker for bladder cancer patients likely to benefit from adjuvant chemotherapy. BMC Cancer (2012) 0.83
Analysis of microsatellite mutations in buccal cells from a case-control study for lung cancer. Cancer Epidemiol (2011) 0.75
Effect of etoposide-induced alteration of the Mdm2-Rb signaling pathway on cellular senescence in A549 lung adenocarcinoma cells. Oncol Lett (2017) 0.75
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer (2006) 6.39
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol (1999) 2.32
The electronic structure of Fe2+ in reaction centers from Rhodopseudomonas sphaeroides. III. EPR measurements of the reduced acceptor complex. Biophys J (1984) 1.85
Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol (1999) 1.74
Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer. Gastroenterology (1998) 1.69
Quality of life during chemotherapy in non-small cell lung cancer patients. Acta Oncol (1989) 1.68
A dysfunctional desmin mutation in a patient with severe generalized myopathy. Proc Natl Acad Sci U S A (1998) 1.61
p53 and proliferating cell nuclear antigen expression in JC virus-infected cells of progressive multifocal leukoencephalopathy. Hum Pathol (1994) 1.51
Acute appendicitis in an incarcerated crural hernia: analysis of our experience. Rev Esp Enferm Dig (2005) 1.49
Etiology of solitary pulmonary nodules in patients with human immunodeficiency virus infection. Clin Infect Dis (1997) 1.48
Complex high-resolution linkage disequilibrium and haplotype patterns of single-nucleotide polymorphisms in 2.5 Mb of sequence on human chromosome 21. Genomics (2001) 1.47
[Mortality following cardiac surgery in the National Health Service Hospitals of the Community of Valencia in 2007: a descriptive analysis]. Rev Esp Anestesiol Reanim (2010) 1.40
[Vibration and acoustic stimulation during labor with external monitoring. Pathology of fetal heart rate]. Rev Chil Obstet Ginecol (1991) 1.39
[Significance of heterozygosity loss in the long arm of chromosome 5 (5q21) in small cell carcinoma of the lung]. Med Clin (Barc) (1997) 1.39
Inflammatory fibroid polyps of the gastrointestinal tract. An immunohistochemical and electron microscopic study. Cancer (1983) 1.29
Protein-cofactor interactions in bacterial reaction centers from Rhodobacter sphaeroides R-26: II. Geometry of the hydrogen bonds to the primary quinone formula by 1H and 2H ENDOR spectroscopy. Biophys J (2006) 1.29
Serum protein binding of propofol in patients with renal failure or hepatic cirrhosis. Acta Anaesthesiol Scand (1996) 1.24
In vitro susceptibilities of aerobic and facultative non-spore-forming gram-positive bacilli to HMR 3647 (RU 66647) and 14 other antimicrobials. Antimicrob Agents Chemother (1998) 1.24
Pathology of a new toxic syndrome caused by ingestion of adulterated oil in Spain. Virchows Arch A Pathol Anat Histol (1982) 1.23
Detection of thyroid hormones in human embryonic cavities during the first trimester of pregnancy. J Clin Endocrinol Metab (1993) 1.18
Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia. J Antimicrob Chemother (2000) 1.15
Serum protein binding of propofol in critically ill patients. Acta Anaesthesiol Scand (1997) 1.11
Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders. Ann Neurol (1999) 1.11
The significance of lipoproteins in serum binding variations of propofol. Anesth Analg (1998) 1.11
Sulbactam efficacy in experimental models caused by susceptible and intermediate Acinetobacter baumannii strains. J Antimicrob Chemother (2001) 1.10
Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients. Eur J Cancer (2009) 1.08
Molecular staging of non-small cell lung cancer according to K-ras genotypes. Clin Cancer Res (1996) 1.05
Thyroid hormones in tissues from fetal and adult rats. Endocrinology (1994) 1.04
On the histogenesis of Ewing's sarcoma. An ultrastructural, immunohistochemical, and cytochemical study. Cancer (1984) 1.02
Recurrent lacunar infarction following a previous lacunar stroke: a clinical study of 122 patients. J Neurol Neurosurg Psychiatry (2007) 1.02
Association of HLA-DR4-Dw15 (DRB1*0405) and DR10 with rheumatoid arthritis in a Spanish population. Arthritis Rheum (1993) 1.01
Community-acquired febrile urinary tract infection in diabetics could deserve a different management: a case-control study. J Intern Med (2003) 1.01
Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine. Lung Cancer (2011) 1.01
Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma. Ann Oncol (2013) 1.01
DEF-3(g16/NY-LU-12), an RNA binding protein from the 3p21.3 homozygous deletion region in SCLC. Oncogene (1999) 1.00
Mutated K-ras gene analysis in a randomized trial of preoperative chemotherapy plus surgery versus surgery in stage IIIA non-small cell lung cancer. Lung Cancer (1995) 1.00
Delayed papillary muscle rupture following mild chest trauma. J Heart Valve Dis (1995) 1.00
Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium. Spanish Oncology Genitourinary Group. J Clin Oncol (2000) 0.99
Preoperative chemotherapy for stage IIIA non-small cell lung cancer. Curr Opin Oncol (1997) 0.98
Protein-cofactor interactions in bacterial reaction centers from Rhodobacter sphaeroides R-26: I. Identification of the ENDOR lines associated with the hydrogen bonds to the primary quinone QA*-. Biophys J (2006) 0.95
Desmin myopathy: a multisystem disorder involving skeletal, cardiac, and smooth muscle. Hum Pathol (1995) 0.95
Cyclin D1 overexpression in non-small cell lung carcinoma: correlation with Ki67 labelling index and poor cytoplasmic differentiation. J Pathol (1996) 0.95
Injury to the infrapatellar branch of the saphenous nerve in ACL reconstruction with the hamstrings technique: clinical and electrophysiological study. Knee (2008) 0.94
Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer. Ann Oncol (2007) 0.94
Outer ring iodothyronine deiodinases and thyroid hormone economy: responses to iodine deficiency in the rat fetus and neonate. Endocrinology (1991) 0.94
Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patients. Ann Oncol (1998) 0.93
Phase II trial of short-term neoadjuvant docetaxel and complete androgen blockade in high-risk prostate cancer. Br J Cancer (2009) 0.93
Long term evaluation of high tibial valgus osteotomy. Int Orthop (1990) 0.93
Thyroid hormones and 5'-deiodinase in the rat fetus late in gestation: effects of maternal hypothyroidism. Endocrinology (1991) 0.93
Rapid quantitative detection of BCR-ABL transcripts in chronic myeloid leukemia patients by real-time reverse transcriptase polymerase-chain reaction using fluorescently labeled probes. Haematologica (2000) 0.93
The ultrastructure of conventional, parosteal, and periosteal osteosarcomas. Cancer (1982) 0.93
L-thyroxine and 3,5,3'-triiodothyronine concentrations in the chicken egg and in the embryo before and after the onset of thyroid function. Endocrinology (1992) 0.93
Binding of propofol to blood components. Br J Clin Pharmacol (2000) 0.92
Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro. J Med Chem (1991) 0.92
Comparison of three protracted antiemetic regimens for the control of delayed emesis in cisplatin-treated patients. Eur J Cancer (1992) 0.92
Giant cell myocarditis: monocytic immunophenotype of giant cells in a case associated with ulcerative colitis. Hum Pathol (1995) 0.92
Microbiological characterization and clinical significance of Corynebacterium amycolatum strains. Eur J Clin Microbiol Infect Dis (1999) 0.92
Plasma protein carbamylation and decreased acidic drug protein binding in uremia. Clin Pharmacol Ther (1980) 0.92
HLA-DRw10 confers the highest susceptibility to rheumatoid arthritis in a Spanish population. Tissue Antigens (1990) 0.92
Signet-ring cell lymphoma. Ultrastructural and immunohistochemical features of three varieties. Cancer (1983) 0.91
Differential expression of CD44v6 in adenocarcinoma of the pancreas: an immunohistochemical study. Virchows Arch (1996) 0.91
Case-control study of risk factors for the development of enterococcal bacteremia. Eur J Clin Microbiol Infect Dis (2001) 0.90
Auditory event-related potentials in 50 melancholic patients: increased N100, N200 and P300 latencies and diminished P300 amplitude. J Affect Disord (2003) 0.90
Genomic variability of Haemophilus influenzae isolated from Mexican children determined by using enterobacterial repetitive intergenic consensus sequences and PCR. J Clin Microbiol (2000) 0.90
K-ras gene point mutation: a stable tumor marker in non-small cell lung carcinoma. Lung Cancer (1994) 0.90
Prognostic value of K-ras mutations and allelic imbalance on chromosome 18q in patients with resected colorectal cancer. Dis Colon Rectum (2001) 0.90
Altered plasma and brain disposition and pharmacodynamics of methadone in abstinent rats. J Pharmacol Exp Ther (1999) 0.90
Time-dependent pharmacokinetics of cyclosporine (Neoral) in de novo renal transplant patients. J Clin Pharm Ther (2005) 0.90
Pharmacokinetic-Pharmacodynamic Modelling of the antipyretic effect of two oral formulations of ibuprofen. Clin Pharmacokinet (2000) 0.89
Adult-onset hypothyroidism and the cerebral metabolism of (1,2-13C2) acetate as detected by 13C nuclear magnetic resonance. Endocrinology (1995) 0.88
Role of CD44 in the invasiveness of glioblastoma multiforme and the noninvasiveness of meningioma: an immunohistochemistry study. Hum Pathol (1995) 0.88
PDH E1β deficiency with novel mutations in two patients with Leigh syndrome. J Inherit Metab Dis (2009) 0.86
Effect of zinc on human sperm motility and the acrosome reaction. Int J Androl (1992) 0.86
The fibromatoses. An ultrastructural study of 31 cases. Pathol Res Pract (1983) 0.86
Etomidate and plasma esterase activity in man and experimental animals. Pharmacology (1979) 0.86
CD44 isoform expression follows two alternative splicing pathways in breast tissue. Am J Pathol (1998) 0.86
Effects of thyroid hormone on the androgenic expression of KAP gene in mouse kidney. Mol Cell Endocrinol (1996) 0.85
[Accident and emergency department inappropriate utilization. An evaluation with explicit criteria]. Gac Sanit (2000) 0.85
Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effects of main active metabolites of tramadol, (+)-O-desmethyltramadol and (-)-O-desmethyltramadol, in rats. J Pharmacol Exp Ther (2000) 0.85
Alpha 1-acid glycoprotein (AAG) and serum protein binding of methadone in heroin addicts with abstinence syndrome. Int J Clin Pharmacol Ther (2000) 0.85
TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis. Oncogene (1997) 0.84
Representativeness of nodal sampling with endobronchial ultrasonography in non-small-cell lung cancer staging. Ultrasound Med Biol (2012) 0.84